ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IMM Immupharma Plc

1.80
-0.10 (-5.26%)
Last Updated: 08:14:38
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -5.26% 1.80 1.905 2.20 1.80 1.80 1.80 108,896 08:14:38
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -1.67 6.33M
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 1.90p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares in issue. The market capitalisation of Immupharma is £6.33 million. Immupharma has a price to earnings ratio (PE ratio) of -1.67.

Immupharma Share Discussion Threads

Showing 14826 to 14849 of 39125 messages
Chat Pages: Latest  605  604  603  602  601  600  599  598  597  596  595  594  Older
DateSubjectAuthorDiscuss
21/2/2018
08:53
news monday 26th .//......
opodio
21/2/2018
08:52
massive buying going on

15k
19k
15k

all buys

looks ready to pop

opodio
21/2/2018
08:51
Anyone got the 700p target note mentioned here yesterday please
opodio
21/2/2018
08:50
The tables have turned. Check out the 5k buys now. WQ buying back! :)
lodgeview
21/2/2018
08:49
Chalky. I have never said don't invest here, I am, just IMHO don't put your future on it!
hamhamham1
21/2/2018
08:48
It's not your job to police this board nor give investment advice so shut up you are making a fool of yourself.
chadders
21/2/2018
08:48
The more Hamham tries to make us sell, the more this goes up.
che7win
21/2/2018
08:47
hhh1 into the filter bin, to join bookbroker and others who have shown no signs of informative discussion of the pros and cons of investing in IMM.
metis20
21/2/2018
08:46
So it's OK to encourage people to invest here but not OK to encourage people to be careful here?
Chadders, tot up all the posts here and put them into piles, how many encourage investing, how many encourage to be careful and how many encourage not to invest at all.
I think you'll find the first lot outweigh the rest by 5 or 10 fold.
Get over it!

hamhamham1
21/2/2018
08:45
She's about to blow!
lodgeview
21/2/2018
08:40
That’s a name you conjured up!
bookbroker
21/2/2018
08:39
Hamham, you're just getting ridiculous now. How do you know the profile of the majority? Since when has anyone asked for a guardian angel? It's clear to me you shouldn't be invested in this with your risk profile and you are constantly seeking validation of your investment strategy.


You are not qualified to give investment advice so stop constantly harping on about the risks. You can kid yourself that you are worried about others but it doesn't fool anyone. Please give it a rest and do another note to oneself.

chadders
21/2/2018
08:38
She must have never tried mdma
spawny100
21/2/2018
08:38
Hammmama

I'm a new investor in this ( since early Jan so in at average £1.50) . I'm risking half my portfolio because I'm mature enough to know what a risk is ... and intelligent enough to know when there is an opportunity to make money ( I have weighed up the risks )
I'm just over 50 and its not everyday I get the chance to invest in something with this potential on the upside , and aware you don't often get these opportunities very often

I imagine most genuine people on this board are fully aware of all the risks , the last thing we all want is someone like you constantly questioning our intelligence and our own judgement

you may think you are doing good .... but have you ever thought that if results are good ( and I believe there is around 70% chance ) you may have stopped a lot of people making money and the one chance they had of making a very good investment choice
I hope you will be able to live with yourself !

Best you just keep your moral opinions to yourself and just focus on the facts or any new news which could be important

chalky230
21/2/2018
08:37
Barbie Manchester said Lupuzor was the best drug she tried.
top tips
21/2/2018
08:34
All Lupuzor needs to do is equal or better Benlysta on efficacy, because we already know we beat it on speed of action, side effects and price.
top tips
21/2/2018
08:31
(and I meant holding some in portfolio at this stage)
hamhamham1
21/2/2018
08:29
top tips. Best statement you have said by far to date. The only small, weeny change I would make would be...
If p3 readout is good, it's such an obvious growth or takeover stock, it makes sense to have some in ones portfolio.

hamhamham1
21/2/2018
08:26
It's such an obvious growth or takeover stock, it makes sense to have some in ones portfolio.
top tips
21/2/2018
08:09
Flavio. yes, IMHO if you are rich then putting a lot of money on this one share doesn't matter as long as you still have plenty left if bad results. But this isn't the profile of the majority of investors here, many will have a smaller vital pot of money that is needed for their future, what do you say to those Flavio?
hamhamham1
21/2/2018
08:08
Should read P140 and its worth billions across multiple indications adding substantially to the value here.
ballsac
21/2/2018
08:05
Quite sad this board has been ruined by so many trolls. It used to be informative and scientific. For anyone new here or already invested do not let these uninformed idiots influence anything.

What we do know is that until the P3 trial results are unblinded and full read out is disclosed nobody knows what the result will be - fact.

However, I remain fully invested on the basis on 5 key facts that I believe are in favour of a clinically statically result and pathway to a Marketing Authorisation.

-Lupuzor appears to be more efficacious than Current GSK therapy
- all reports to date indicate a very clean side effect profile
- it will be priced lower than current therapy
- both Clinicians and Patients requested continued/new access to Lupuzor on an open trial basis. There really is one conclusion to such requests IMO
- P140 platform could have significant potential for further indications and markets

The choice is very simple. You are either in or out at the point the RNS Lands in the next 4-5 weeks.

adorling
21/2/2018
07:57
Still not believe him!
bookbroker
21/2/2018
07:53
jolly bookbroker what if "Lyin Tim" did come back the truth and phase 3 shows great results? What will you do then?
jollychap
Chat Pages: Latest  605  604  603  602  601  600  599  598  597  596  595  594  Older

Your Recent History

Delayed Upgrade Clock